John Latham
Consultant / Advisor bei Accelerator Services Corp
Profil
John A.
Latham was the founder of Lundbeck Seattle BioPharmaceuticals, Inc. founded in 2004, where he held the title of Chief Scientific Officer from 2012 to 2019.
He also held founding positions at Darwin Molecular Corp as Founding Director from 1994 to 1998, and at Gilead Sciences, Inc. as Principal from 1989 to 1994.
He was also VP-Gene Function & Target Validation at Celltech Group Plc from 1998 to 2004.
Currently, Dr. Latham serves as an Advisory Board member at Accelerator Services Corp.
Dr. Latham holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Colorado State University.
Aktive Positionen von John Latham
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von John Latham
| Unternehmen | Position | Ende |
|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Founder | 05.04.2019 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | 01.01.2004 |
Darwin Molecular Corp
 Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The private company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Corporate Officer/Principal | 01.01.1998 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.1994 |
Ausbildung von John Latham
| Massachusetts Institute of Technology | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Darwin Molecular Corp
Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The private company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
